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Abstract
Two vaccinia virus temperature-sensitive mutants were mapped to the E8R gene and subjected to phenotypic characterization. Dts23 contains a
missense mutation in the coding region of E8R (L81F), and in Cts19 the initiating methionine codon is changed from ATG to ATA (M1I). The two
ts mutants display normal patterns of gene expression and DNA replication during infection. The E8 protein is synthesized exclusively late during
infection and packaged into virion cores Western blot analysis revealed that E8 synthesis is reduced in Dts23 infected cells at permissive (31 °C)
and non-permissive temperature (39.7 °C) and absent in Cts19 infection under both conditions. Dts23 virions produced at 39.7 °C were
indistinguishable in appearance from wt virions. Cts19 fails to produce identifiable viral structures when incubated at 39.7 °C. Purified Dts23
virions produced at 39.7 °C contain reduced amounts of E8 and have a high particle to infectivity ratio; purified Cts19 virions grown at 31 °C also
show reduced infectivity and do not contain detectable E8. Dts23 grown at 39.7 °C could enter cells but failed to synthesize early mRNA or
produce CPE. Soluble extracts from mutant virions were active in a promoter dependent in vitro transcription assay, however intact mutant cores
were defective in transcription. We suggest that E8 plays a subtle role in virion core structure that impacts directly or indirectly on core
transcription.
Published by Elsevier Inc.Keywords: Vaccinia virus; Poxvirus; Temperature-sensitive mutant; Virus genetics; Virus assembly; Virus transcriptionIntroduction
The family Poxviridae comprises large dsDNA viruses that
replicate in the cytoplasm of infected cells. Vaccinia virus
(VACV), the prototype of this family, encodes more than 200
genes that function in viral RNA synthesis, genome replication,
virion assembly and host defense (Moss, 2007). The vaccinia
virion is complex and unusual in structure. The DNA genome is
packaged in a biconcave, walled core structure which is flanked
by protein-containing “lateral bodies”; the core and lateral
bodies are encased in a proteolipid membrane to form a brick-
shaped virion. The virion contains approximately 75 proteins, of
which one third are enzymes involved in early mRNA synthesis,⁎ Corresponding author. Department of Molecular Genetics and Microbiol-
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membrane structural proteins (reviewed in Condit et al., 2006).
VACV enters cells either by fusion of the viral membrane
directly with the host cell plasma membrane or by endocytosis
followed by fusion of the viral membrane with the vesicle
membrane, in either case resulting in the release of the viral core
and lateral bodies into the cytoplasm (Moss, 2006). The viral
transcription machinery is then activated and early transcripts
are synthesized and translated on cellular ribosomes. Early viral
proteins catalyze DNA replication and intermediate viral mRNA
synthesis; intermediate gene products in turn activate late gene
transcription (reviewed in Broyles, 2003; Condit and Niles,
2002; Moss, 1994). The replicative cycle culminates with
morphogenesis of new virions, assembled from late viral gene
products (Condit et al., 2006).
As assessed by electron microscopy, the first indication of
virus replication is the development of DNA enriched structures,
named DNA factories, in the cytoplasm of infected cells (Condit
et al., 2006). These factories have been shown to be the site of
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factories are frequently surrounded membrane cisternae derived
from the endoplasmic reticulum (ER) (Doglio et al., 2002;
Tolonen et al., 2001). At later times when virion morphogenesis
begins within the factories, the membranes surrounding the
factories disappear. Virion morphogenesis within DNA factories
begins with formation of viral membranes in the shape of
crescents. Crescents evolve into spherical immature viral
particles (IV), which ultimately morph into the brick-shaped
mature virions (MV) described above (Condit et al., 2006).
We report here the phenotypic characterization of tempera-
ture-sensitive mutants in a vaccinia virion structural protein, E8.
Our attention was drawn to E8 because of reports from Locker
and coworkers (Doglio et al., 2002; Schramm and Krijnse-
Locker, 2005; Tolonen et al., 2001; Welsch et al., 2003)
suggesting that E8 might mediate the interaction between ER
cisternae and developing DNA factories. These authors reported
that E8 is expressed early during infection, contains two putative
transmembrane domains, and is associated with membrane
structures during infection, in particular with the ER cisternae
surrounding early DNA factories. They reported further that E8
is a phosphoprotein whose phosphorylation is modulated during
infection and that it localizes to cores in MV. To further
investigate the function of E8 in viral replication, we char-
acterized two temperature-sensitive (ts) mutants, Dts23 and
Cts19, from the same complementation group (Lackner et al.,
2003). Our phenotypic analysis of these mutants is generally
inconsistent with a role for E8 early in VACV morphogenesis.
We find instead that E8R mutants were able to form
morphologically normal virus particles under non-permissive
conditions; however purified mutant virions are significantly
reduced in both infectivity and transcriptional activity. The
possible role of the E8R gene product in VACV biology will be
discussed.
Results
Mutations in the E8R gene confer the ts phenotype in Dts23,
Dts25 and Cts19
The analysis of the merged Condit and Dales collections of
VACV ts mutants has placed three mutants, Dts23, Dts25 and
Cts19 in the same complementation group (Lackner et al.,
2003). To map the mutations in these viruses to a single gene,
we applied a one step marker rescue protocol using a library of
PCR fragments of approximately 18 kbp that extend over the
entire VACV genome (Yao and Evans, 2003). Briefly, confluent
monolayers of BSC40 cells were infected with Dts23, Dts25 or
Cts19 and transfected with the PCR products. Cells were
incubated at 39.7 °C for 4 days, followed by crystal violet
staining. The appearance of viral plaques in the monolayer
indicates the rescue of the mutation. The results showed that all
three mutations rescued with the PCR product YE3 that extends
from gene F14L (WR53) to O1l (WR68) (Fig. 1 and data not
shown). A second set of amplicons of approximately 5 kbp that
cover the region defined by YE3 was used to refine the
mapping. The results show that the lesion maps within theregion defined by the PCR product LM13, comprising genes
E6R (WR062) to E9L (WR065) (Fig. 1 and data not shown). To
finally map the mutations to a single gene, a third set of PCR
products were prepared representing each individual gene from
the region defined by LM13. Our results show that Dts23 (Fig.
1A) and Dts25 (data not shown) were rescued with the E8R
amplicons.
Several attempts were made to rescue Cts19 with a single
gene but all failed to provide a positive result. Therefore, a
modified approach was taken in which adjacent pairs of open
reading frames in a single amplicon used for marker rescue. As
shown in Fig. 1B the amplicon that includes both the E7R and
E8R genes was able to rescue the Cts19 mutation.
To identify the precise mutation responsible for the ts
phenotype in Dts23, Dts25 and Cts19, the complete E8R gene
of each mutant was sequenced. In addition, the E7R gene was
sequenced from the Cts19 mutant. Dts23 and Dts25 mutants
have a C to T transition in nucleotide 241, substituting a phenyl-
alanine for leucine at codon 81 (L81F). Thus both Dts23 and
Dts25 have the same point mutation in the E8R gene and there-
fore the characterization of Dts25 was discontinued. The E7R
gene from Cts19 was wt in sequence. In gene E8R, the Cts19
mutant has a G to A transition in nucleotide 3 substituting an
isoleucine for the initiating methionine (M1I). The proximity of
the Cts19 mutation to the 5′ end of the E8R gene is consistent
with the fact that we were only able to rescue the mutant using an
amplicon containing both the E7R and E8R genes. Furthermore,
the Cts19 mutation abolishes the translation initiation codon of
the E8R gene; the next possible initiation codon is 90 nucleotides
downstream. Thus, we speculate that Cts19 is a null mutant.
One-step growth curve of Dts23 and Cts19
To analyze the growth characteristics of the mutants we
performed one-step growth experiments. Since Dts23 mutant is
in a VACV-IHDW background and Cts19 is in a VACV-WR
background, we compared each mutant growth to its own
parental type. BSC40 cells were infected with an MOI of 10
with either wild type or mutant virus at permissive and non-
permissive temperatures. At different times post-infection, the
cells were harvested and the amount of virus in each sample
determined by plaque assay at 31 °C (Fig. 2). VACV-IHDW
was able to grow at both 31 °C and 39.7 °C and produced a
maximum of 63 and 66 pfu per cell after 48 or 36 h post-
infection, respectively. On the other hand, Dts23 produced 65
pfu per cell at permissive temperature but only 0.35 infectious
particles per cell at non-permissive temperature. Cells infected
with VACV-WR were also able to grow at permissive and non-
permissive temperatures and produced a maximum of 264 and
188 pfu per cell after 48 and 36 h, respectively. Cts19 failed to
generate a large amount of infectious particles at either
temperature. At the permissive temperature, Cts19 produced a
maximum of 4 pfu per cell, and only 1 infectious particle per
cell was recovered at the non-permissive temperature. Since
Cts19 replication was defective even at the permissive
temperature, most of the remaining characterization of E8R
gene function was done using Dts23.
Fig. 1. One-step marker rescue of E8R mutants. BSC40 cells were infected with Dts23 or Cts19 mutant virus and transfected with a PCR product as described in
Materials and methods. Crystal violet-stained dishes are shown, labeled with the PCR amplification used in the transfection as shown in the drawing on the top of the
figure. (A) Dts23; (B) Cts19.
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mutants at the non-permissive temperature
To determine whether the mutation in the E8R gene would
alter the synthesis of macromolecules, we measured the DNA
accumulation and protein synthesis in cells infected at
permissive and non-permissive temperatures. Cells were
infected with the wt and Dts23 viruses at 31 or 39.7 °C and at
various times after infection the cells were harvested and
prepared for DNA slot blot analysis. Cell lysates were applied to
a slot-blot membrane, hybridized to a 32P-labeled vaccinia
DNA probe, and quantified using a phosphor-imager (Fig. 3).
The results show that wt and mutant virus were able to
synthesize DNA at the same level at both temperatures. It has
been reported previously that Cts19 is not defective in DNA
replication under non-permissive conditions (Condit and
Motyczka, 1981).
Since DNA synthesis was not impaired in Dts23 incubated at
39.7 °C we next examined if there was any alteration in protein
synthesis in cells infected with the mutant viruses. Cells were
infected with wt and mutant virus at permissive and non-
permissive temperatures and at various times after infection
protein synthesis was evaluated by metabolic labeling with 35S-
methionine in a 30 minute pulse. Labeled proteins were
separated by SDS–PAGE and analyzed by autoradiography(Fig. 4). We observed the typical pattern of protein synthesis in
wt infected cells incubated at 31 and 39.7 °C. At 3 h post-
infection early viral proteins began to be synthesized and at the
same time cellular protein synthesis began to shut-off. By 6 h
post-infection a new set of viral proteins representing post-
replicative gene products appeared and persisted throughout the
course of the infection. Dts23 infected cells incubated at both
temperatures presented a pattern of protein synthesis indis-
tinguishable from that which was observed in wt infected cells.
Early viral proteins were detected at 3 h post-infection and a late
pattern was recognized at 6 h post-infection and persisted
throughout the course of infection. It has been reported
previously that no modification of the pattern of viral protein
synthesis is observed in Cts19-infected cells incubated at
permissive and non-permissive temperatures (Condit and
Motyczka, 1981).
Electron microscopic analysis of Dts23 and Cts19-infected
cells
Transmission electron microscopy (TEM) has been used to
identify the different steps of virus morphogenesis. The VACV
maturation cycle is a relatively non-synchronous event and at
late times of infection all stages of morphogenesis can be
identified. To determine whether viral assembly was affected by
Fig. 2. One-step growth of wt, Dts23 and Cts19 viruses. BSC40 cells were infected at moi=10 pfu/cell with wt or mutant viruses, incubated at 31 or 39.7 °C for the
indicated periods of time (abscissa), and virus yields were determined by plaque titration at 31 °C (ordinate). (A)WR-wt; (B) Cts19; (C) IHDW-wt; (D) Dts23 (31 °C—
●; 39.7 °C—■).
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VACV mutants at the permissive and non-permissive tempera-
ture and at various times the cells were collected and processed
for TEM (Fig. 5). No differences in virus formation were
observed in cells infected with Dts23 at either the permissive or
the non-permissive temperature (Figs. 5A–D). All stages of
virus morphogenesis could be observed Dts23 infected cells
incubated at 31 °C (Fig. 5A). In Dts23 infected cells incubated
at the non-permissive temperature we could identify the
presence of crescents, IV, IVN and MV with no perceptible
difference in structure (Figs. 5B–D). The presence of WV and
EV could also be recognized in Dts23 infected cells at 39.7 °C
(Fig. 5 inset).
Similar to Dts23, no difference in virus morphogenesis could
be observed in Cts19-infected cells and incubated at 31 °C
where IV and MV were clearly identified (Figs. 5E, F).
However, when Cts19-infected cells were incubated at 39.7 °Cwe observed DNA factories and occasional aggregates of
presumed aberrant virus structures (Fig. 5G), however we
observed no MV formation and only rarely could IV structures
were seen in the cytoplasm of cells after meticulous search
(Figs. 5G, H).
Kinetics of synthesis and accumulation of E8 in wt and mutant
virus infected cells
It has been reported previously that the E8 protein is
synthesized early during vaccinia infection (Doglio et al.,
2002). However, inspection of the DNA sequence of the E8R
gene reveals the presence of two early transcription termination
sequences embedded well within the coding sequence and a
sequence consistent with an intermediate or late gene promoter
immediately upstream of the coding sequence. We therefore
thought it important to reinvestigate the kinetics of E8 synthesis
Fig. 4. Protein synthesis in wt and mutant-infected cells. BSC40 cells were
infected at moi=10 pfu/cell, incubated at 31 or 39.7 °C and pulse-labeled with
35S-methionine at various times post-infection, indicated in hours at the top of
each autoradiogram. Cells lysates were electrophoresed on SDS–PAGE, and
gels were dried and autoradiographed. Incubation temperature and time of the
pulse label are indicated at the top of each column, and the mutant used in the
infection is indicated to the left of each row of autoradiograms. Approximate
molecular weights, in kDa, are indicated to the right of each autoradiograms.
Fig. 3. Viral DNA replication in virus infected cells. BSC40 cells were infected
at moi=10 pfu/cell, incubated at 31 or 39.7 °C, and at indicated times post-
infection, cell extracts were prepared and applied on nylon membranes, and
hybridization to a 32P labeled vaccinia virus DNA probe was performed as
described under Materials and methods. The numbers (arbitrary units) express
the average value of three different measurements. (A) IHDW-wt; (B) Dts23
(31 °C—●; 39.7 °C—■).
402 S.E.M. Kato et al. / Virology 367 (2007) 398–412during virus infection. BSC40 cells were infected with the wt
and mutant viruses, incubated at permissive and non-permissive
temperatures, and at various times after infection cells were
harvested and the samples analyzed by Western blot using an
anti E8 anti-peptide antibody. Fig. 6 shows that in cells infected
with either wt VACV or Dts23 at both permissive and non-
permissive temperatures, E8 protein appears at 6 h post-
infection and persists throughout the course of the infection.
The level of E8 accumulation in the Dts23 virus infections is
significantly reduced compared to wt infection. No difference in
E8 accumulation was observed in Dts23 infected cells incubated
at permissive compared to non-permissive temperatures. As
expected, in Cts19-infected cell there was no indication of E8
synthesis at any time during infection. The Western blot
presented in Fig. 6 also shows a 35 kDa cross-reacting protein
that accumulates late during infection. This protein was not
present in mock-infected cells but was present in Cts19-infected
cells. We could not establish if this cross-reactive polypeptide
was derived from a virus encoded gene or if it had a cellular
origin that is induced during virus replication, however its
presence in Cts19 infections clearly indicates that it is notderived from the E8 gene. Since a blast search of the 14-amino
acids used to raise the E8 antibody did not reveal any other
cellular or viral proteins besides the E8 ortholog, we assume
that this signal was due to a non-specific reaction.
The kinetics of accumulation of E8 (Fig. 6) suggests that the
E8R gene is expressed specifically late during infection. To
verify the temporal class of E8R gene expression, cells were
infected in the absence or in the presence of cytosine
arabinoside (CAR) and at various times cells were harvested
and processed for Western blot analysis as described in
Materials and methods. Early protein synthesis is not inhibited
by CAR. By contrast, intermediate and late gene expression is
dependent DNA replication and therefore inhibited by CAR.
Two VACV proteins were used as markers for early (gene F11L)
or late (gene L4R) gene expression. In Fig. 7 we show that F11
appeared by 2 h post-infection and its synthesis was not
inhibited by the addition of CAR. One the other hand, L4 did
not accumulate until 5 h post-infection and its synthesis was
inhibited by the drug. E8 displayed a late pattern of
accumulation similar to L4 since the protein did not accumulate
until the 5 h post-infection and was inhibited by the addition of
CAR. We conclude that E8R is a post-replicative gene, contrary
to published reports (Doglio et al., 2002). The late expression of
the E8 R gene has also been confirmed by R. Jeremy Nichols
and P. Traktman (personal communication).
Characteristics of Dts23 and Cts19 the purified particles
To examine further the mutant virus particles we purified
virions from infected cells incubated permissive and non-
Fig. 5. Electron micrographs of wt and mutant-infected cells. BSC40 cells were infected with wt or mutant virus at an moi=10 pfu/cell, incubated at 31 or 39.7 °C for
16 h (D); 24 h (A–C, E, G; inset); 36 h (H) and 48 h (F) and processed for electron microscopy as described in Materials and methods. IV=immature virions;
MV=mature virions; WV=wrapped virions; EV=extracellular virions; C=crescents; N=nucleus; F=DNA factories. (A) Dts23 infections at 31 °C; (B–D) Dts23
infections at 39.7 °C; (E–F) Cts19 infections at 31 °C; (G–H) Cts19 infections at 39.7 °C. The inset in C shows the formation of WVand EV in Dts23 infections. Scale
bar=1 μm.
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gradient sedimentation from infected cells incubated at 31 and
39.7 °C and from Cts19-infected cells incubated at 31 °C, as
described in Materials and methods. As shown in Table 1 wt and
mutant viruses produce approximately the same number of
particles per cell regardless of the temperature of incubation.
However the specific infectivity (particles/pfu) of the isolated
particles can vary depending on the mutant or the incubation
conditions. The specific infectivity of Dts23 grown at 39.7 °C is
reduced nearly 35 fold compared to the specific infectivity ofthe same virus produced at 31 °C. The specific infectivity of
Cts19 particles grown at 31 °C was 38 fold lower than wt virus
grown under the same conditions. No significant difference in
specific infectivity was observed between wt grown at both
permissive and non-permissive temperatures, and Dts23 grown
under permissive conditions had a specific infectivity equiva-
lent to wt virus.
The protein content of purified virions was examined by
SDS–PAGE (Fig. 8). Comparing the WR and IHDW strains,
two differences in protein composition could be easily identified
Fig. 6. Accumulation of E8 in wt and mutant virus infected cells. BSC40 cells were infected with wt or mutant virus at an moi=10 pfu/cell and incubated at 31 or
39.7 °C. At different times, indicated in hours on the top of each lane, samples were removed and processed for Western blot as described under Materials and methods.
The arrow represents the expected MW for the E8 protein. Approximate molecular weights, in kDa, are indicated to the right of the F.
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picuous difference between wt and mutant virions could be
observed within each strain using this analysis. The content of
DNA in purified virions was examined by pulse-field electro-
phoresis. No differences in size and in the content of DNA per
particles were observed comparing wt and mutants grown at
different conditions (data not shown).
Doglio et al. (2002) reported that E8 partitioned into the core
fraction after treatment of virions with detergent and a thiol
reducing agent. To confirm this observation and to analyze the
integrity of the mutant particles, virions were treated with NP40
and DTT, core/precipitate and membrane/soluble fractions were
separated by centrifugation and the samples were analyzed by
Western blot (Fig. 9). Our results show that indeed E8
partitioned in the core fraction and there was no difference in
the amount of E8 present in wt virions compared to Dts23Fig. 7. Kinetics of synthesis of E8. BSC40 cells were infected with VACV-WR at an
40 μg/ml of CAR (A). At 1, 2, 3, 5, 6, and 8 h post-infection samples were removed a
are mock-infected cells incubated in the absence or presence of CAR. Approximatevirions purified from 31 °C infections. A lower amount of E8
was observed in Dts23 virions purified from 39.7 °C infections
and E8 was absent from Cts19 virions. The analysis of other
viral proteins present in core and membrane fractions revealed
no difference in quantities when wt and mutant virus were
compared. A27, a viral membrane protein, partitioned into the
supernatant and two core proteins, L4, a single stranded DNA
and RNA binding protein, and H4, an early-stage transcription
factor, partitioned into the core fraction.
Mutant particles can penetrate BSC40 cell but do not induce
cytopathic effect and do not synthesize early viral mRNA
To determine whether Dts23 virions purified from 39.7 °C
infections could initiate a cycle of infection we examined
whether the virions were able to penetrate cells, induce amoi=10 pfu/cell and incubated at 37 °C in the absence (C) or in the presence of
nd prepared for Western blot as described in Materials and methods. M and MA
molecular weights, in kDa, are indicated to the right of the autoradiograms.
Table 1
Characteristics of purified wt and mutant vaccinia virus particles
Virus—Temperature a Yield (particles/cell) b Infectivity (particles/pfu)
WR-37 °C 3150 19
Cts19-31 °C 1000 737
Dts23-31 °C 1736 22
Dts23-40 °C 1344 775
IHDW-31 °C 852 9
IHDW-40 °C 988 11
a WR wt virus grown at 37 °C from a low moi infection; Cts19 virus grown at
31 °C from a low moi infection. IHDW and Dts23 were isolated from high moi
infections. Viruses grown at 39.7 °C were incubated for 24 h; viruses grown at
31 °C were incubated for 72 h.
b Calculated from an A260 nm reading of purified virus, assuming a 1
A260 nm=1.2×10
10 particles/ml.
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the entry process BSC40 cells were infected with virus for
30 min at 4 °C. After this adsorption period, the inoculum was
removed, medium containing 100 μg/ml of cycloheximide was
added to the cells and incubation was continued at for 2 h at
31 °C. The presence of viral cores inside the cells was detected
by confocal microscopy after labeling the cells with anti-A4
antibody. As shown in Figs. 10D and F, Dts23 virions purified
from 39.7 °C infections were able to enter cells with an
efficiency equivalent to control infections (Figs. 10A–C). These
results show that the mutation in the E8 protein does not affect
binding of virions to cells, or uptake of virions into cells and
uncoating.
We next examined the ability of Dts23 virions purified from
39.7 °C infections to induce CPE in infected cells. For this
purpose, cells were infected with wt or mutant virions purified
from cells infected under permissive or not permissiveFig. 8. Analysis of proteins of purified wt and mutants virions. 0.18 A260 nm units
(12 μg) of purified virions was resuspended in SDS-sample buffer, the proteins
were separated in an 11% SDS–PAGE and stained with Coomassie blue as
described in Materials and methods. The virion analyzed in labeled on the top of
each lane: WR, wt; C-19, Cts19 grown at 31 °C; I-31, IHDW grown at 31 °C;
I-40, IHDW grown at 39.7 °C; D-31, Dts23 grown at 31 °C; D-40, Dts23 grown
at 39.7 °C.Molecular weightsmarkers are indicated to the right of the gel, in kDa.conditions. Infected cells were then incubated under permissive
conditions and the CPE was evaluated 18 h post-infection.
Dts23 virions purified from 39.7 °C infections were not able to
induce CPE while the other samples produce extensive
alteration in the cell morphology (data not shown).
Finally, we analyzed whether Dts23 virions purified from
39.7 °C infections have the ability to direct synthesis of early
viral transcripts in vivo. Cells were infected with wt or mutant
virions purified from cells infected under permissive or not
permissive conditions. Infected cells were then incubated under
permissive conditions, total RNA was isolated at 3, 6 and 9 h
post-infection and the presence of early mRNAwas analyzed by
Northern blot (Fig. 11A). As expected, early transcription was
detected in wt infected cells at both 31 °C and 39.7 °C, and in
Dts23 infected cells at 31 °C. By contrast, no early mRNAwas
detected up to 9 h following infection with Dts23 virions purified
from 39.7 °C. We conclude that Dts23 virions purified from
39.7 °C infections are defective in early viral mRNA synthesis in
vivo.
Mutant particles are defective in core mRNA synthesis
Vaccinia virions package all the enzymes necessary for
synthesis, capping and polyadenylation, of early viral mRNA
and extrusion of the mRNA from the virion core (Moss, 1994).
Transcriptional activation can be achieved in vitro by incubating
virions with a non-ionic detergent, a reducing agent and
nucleoside triphosphates (Kates and McAuslan, 1967).
Extruded RNA can be separated from the core by centrifuga-
tion, where the core associated RNA is recovered in the pellet
and the released RNA is partitioned in the supernatant (Kato et
al., 2004b). To evaluate the transcription capacity of the mutant
viruses, virions purified from cells infected under permissive
and non-permissive conditions were activated and assayed for
RNA synthesis (Fig. 11B). VACV IHDW virions grown at both
the permissive and non-permissive temperature synthesized
viral RNA at the same rate, and equivalent amounts of RNA
were synthesized after 60 min of incubation (Fig. 11B, left).
Although the total amount of RNA synthesized by the WR
strain was lower than the IHDW strain, the kinetics of RNA
synthesis in both cases were comparable (Fig. 11B, right).Fig. 9. Western blot analysis of virions core and membrane fractions. 0.06
A260 nm units (0.7 μg) of each virion sample, labeled as described in Fig. 8, was
resuspended in core buffer and processed as described under Materials and
methods. The gene product corresponding to each antiserum used is indicated to
the left of each row; the virus sample probed is indicated on the top of each lane
where P=pellet/core fraction and S=soluble/membrane fraction; the molecular
weight markers are indicated on the right side of the blot, in kDa.
Fig. 10. Analysis of entry process of wt and mutants. BSC40 cells were infected with moi=1000 particles of each virus grown at 31 °C (A, C) or 39.7 °C (B, D, F),
fixed, permeabilized, stained for the viral core protein A4 (green) and for DNA (blue), and analyzed by confocal microscopy as described in Materials and methods.
IHDW=A, B; Dts23=C, D, F; mock-infected (E).
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synthesize RNA at the rate similar to WT virions grown under
the same conditions and similar amounts of transcripts
accumulated. However Dts23 virions purified from 39.7 °C
infections were defective in transcription and produced only
10% the amount of RNA produced by wt IHDW virions (Fig.
11B, center). Cts19 virions were also defective in transcription,
producing only 25% the amount of RNA produced by wt WR
virions (Fig. 11B, right). The small amount of RNA synthesized
by Dts23 and Cts19 mutant virions was extruded from cores
normally (data not shown).
Soluble virion extracts from mutant particles can transcribe
DNA in a template dependent system
To determine whether Dts23 virions purified from 39.7 °C
infections contain the normal complement of viral RNA
polymerase and transcription initiation factors, a sodium
deoxycholate soluble virion extract was prepared and assayed
for promoter-specific transcription. Virion extracts were incu-
bated in the presence of 32P-rNTP with a linearized dsDNA
containing a vaccinia-specific early promoter upstream of a 375
nt G-less cassette. As shown in Fig. 11C extracts from both wt
and mutant virions purified from cells infected under both
permissive and non-permissive conditions were able to
synthesize the expected 375 nt RNA transcript. We conclude
from this experiment that the mutant virions contain the normalcomplement of active viral RNA polymerase and early
transcription initiation factors.
Discussion
To better understand the role of E8 in the VACV replicative
cycle we have characterized two temperature-sensitive mutants
in this gene. The two mutants are radically different in genotype
and have related but distinct phenotypes. Dts23 produces
reduced amounts of the E8 protein at both permissive and
non-permissive temperatures; it packages significantly reduced
amounts of E8 protein into virions at the non-permissive
temperature and normal amounts at the permissive temperature.
It is not clear at this point whether the transcriptional defect
found in Dts23 virions produced at the non-permissive
temperature results from the reduced amount of E8 present in
virions, or from the fact that the E8 protein packaged is mutant,
or both. In Cts19 the translation initiation codon for the E8
protein is changed from the wt ATG to ATA, and it produces no
detectable E8 protein at either the permissive or the non-
permissive temperature; Cts19 therefore is formally a null
mutant. Consistent with this genotype, the virus grows very
poorly even at the permissive temperature and not at all at the
non-permissive temperature. Interestingly, the phenotype of
Cts19 at the permissive temperature resembles the phenotype of
Dts23 at the non-permissive temperature: at 31 °C Cts19
produces a normal burst of virions, however the virions
Fig. 11. In vivo and in vitro RNA synthesis of purified virions. (A) Northern blot analysis of wt and mutants infected cells. BSC40 cells were infected with the indicated
virus at moi=1000 particles per cell and incubated at 31 °C. At 3, 6 and 9 post-infection samples were removed and prepared for Northern blot. Following pre-
hybridization, 1×107 cpm of a riboprobe, synthesized from the C11R gene, was added to the blot and incubated overnight at 55 °C as described in Materials and
methods. The virion analyzed in labeled on the top of each lane: WR, wt; C-19, Cts19 grown at 31 °C; I-31, IHDW grown at 31 °C; I-40, IHDW grown at 39.7 °C; D-
31, Dts23 grown at 31 °C; D-40, Dts23 grown at 39.7 °C; the molecular weight markers in the right in kb. (B) RNA synthesis directed by purified wt and mutants
particles. Purified virions were permeabilized with NP40 and DTT treatment, incubated with [α32P] CTP and the other nucleotides for 90 min. At indicated times,
samples were removed, and the acid precipitable radioactivity was determined as described in Materials and methods. The virions were labeled as above. (C) Specific
early transcription directed by wt and mutant virion extracts. Soluble transcription extracts were prepared by incubating purified VACV cores with sodium
deoxycholate and passing through a DEAE-cellulose column. The active fractions were pooled, assayed for specific early transcription, and the product analyzed by
electrophoresis on denaturing polyacrylamide gel as described in Materials and methods. The virions were labeled as above; the molecular weight marker indicated at
the right in nucleotides.
407S.E.M. Kato et al. / Virology 367 (2007) 398–412produced have a low infectivity and the virions are defective in
transcription in vitro. The results from these two mutants
together suggest that when the E8 protein is limiting in amount
or absent or poorly packaged, then depending on the temperature
of incubation, transcriptionally defective virions are produced
which are otherwise morphologically normal in appearance. At
the non-permissive temperature, Cts19 presents yet another
phenotype. Gene expression and DNA replication are unaf-
fected, and viral DNA factories are formed, however virus
assembly seems to be interrupted at a very early stage, with only
occasional immature particles and aberrant structures present.
This suggests that in addition to a role in virion transcription, the
E8 protein may also play a role early during virus assembly. The
question of a dual role for E8 during infection might ultimately
be addressed by use of amutant carrying an inducible copy of the
E8 gene. Based on our results we would predict that such a
mutant would have a temperature-sensitive phenotype when E8
expression is repressed. Use of an inducible mutant to titrate the
amount of E8 present during infection might provide further
insight into possible roles of E8 in morphogenesis and in virion
transcription.
Locker and coworkers first observed that vaccinia DNA
factories are temporarily wrapped in ER membrane early during
their evolution and they suggested that this process is mediated
at least in part by the E8 protein (Doglio et al., 2002; Schramm
and Krijnse-Locker, 2005; Tolonen et al., 2001; Welsch et al.,2003). E8 was first implicated in ER wrapping of viral DNA
factories through a screen of the vaccinia genome for proteins
which contained transmembrane domains and which, based on
promoter sequence analysis, might be expressed early during
infection. E8 does contain two putative transmembrane
domains, and subsequent studies by the same group suggested
that the protein was indeed expressed early and that it decorated
the ER membranes that surround viral DNA factories (Doglio
et al., 2002; Schramm and Krijnse-Locker, 2005). Locker and
coworkers also reported that E8 is a phosphoprotein and a target
for the viral F10 kinase in vitro and that it has DNA-binding
activity (Doglio et al., 2002). It should be noted that the
evidence that E8 is actually embedded in membranes in infected
cells is inconclusive. While immunofluorescence and immu-
noelectron microscopy localize E8 to the nuclear envelope, ER
and ER surrounding the DNA factories, E8 is not efficiently
inserted into membranes either co-translationally or post-trans-
lationally, and it does not behave like an integral membrane
protein as assessed by sodium carbonate extraction of mem-
branes from infected cells. It therefore seems possible that the
two hydrophobic regions in E8 in fact do not function as
transmembrane domains, but rather that these regions give the
protein hydrophobic character relevant to its localization and
function in the virus core.
Our results are largely inconsistent with a role for E8 in
mediating ER wrapping of viral DNA factories. First, our results
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examination of the E8 DNA sequence is consistent with this
finding, revealing both internal early gene transcription
termination signals and upstream late promoter elements.
Second, if ER wrapping of viral DNA factories were an
obligatory feature of viral replication, one might expect that a
mutant defective in this process would be defective in viral DNA
replication or formation of DNA factories. In fact, at the non-
permissive temperature Cts19 mutants are interrupted at an early
stage of morphogenesis, a phenotype which is not completely
inconsistent with a role for E8 in evolution of DNA factories.
However, at 31 °C Cts19 forms mature, transcriptionally in-
active virions in the apparent absence of E8 protein, and Dts23
displays a similar phenotype at 39.7 °C. Thus the bulk of our
phenotypic analysis points away from a role for E8 in DNA
factory structure or function and rather toward a role in the fine
structure and/or transcriptional activity of mature vaccinia
virions, discussed below.
Vaccinia early gene transcription has been studied in vitro in
two significantly different experimental contexts: using intact
virion cores or using a soluble transcription system. As
described in Fig. 11B, virion cores can be activated by
treatment of virions with a neutral detergent and a reducing
agent such that they become permeable to added nucleoside
triphosphates (Kates and McAuslan, 1967). Activated cores
synthesize, cap and polyadenylate authentic early viral mRNA
and extrude the RNA from the cores in an energy dependent
fashion (Moss, 1994). The soluble system (Fig. 11C) consists of
a deoxycholate extract of cores (Moussatché, 1985; Rohrmann
and Moss, 1985). This enzyme extract is capable of accurate
transcription initiation and termination from an exogenously
added DNA template, and the extract also contains the enzymes
required for capping and polyadenylation of this RNA. All of
the activities required for mRNA synthesis and modification in
the soluble system have been identified, including initiation
factors, termination factors, the RNA polymerase, the capping
enzyme and the poly (A) polymerase (reviewed in Broyles,
2003; Condit and Niles, 2002; Moss, 1994). Importantly, E8 has
not been identified as a component of the soluble transcription
system, and our results show that extracts from our E8 deficient
virions are competent for promoter-specific transcription in
vitro. Interestingly, several VACV gene products have been
identified which are not required for transcription or RNA
modification in the soluble system but are required for
transcription in activated cores. These proteins fall into two
categories. One category includes proteins which are clearly
structural in nature and have an overt impact on virion
maturation. Mutations in such proteins cause production of
aberrant virions that are transcriptionally inactive but contain all
the enzymes required for accurate transcription in a soluble
system (Kato et al., 2004b). In another category, proteins have
been identified which when mutated produce virions that are
indistinguishable in appearance from wt particles and contain
the normal complement of transcription enzymes as assayed in
the soluble system, but the virions produced, while capable of
entering cells, are transcriptionally inactive and hence non-
infectious. The mutants which produce virions with this latterphenotype affect two classes of core proteins, specifically
proteins with an enzymatic activity or proteins that have
exclusively a structural role. Proteins in the enzymatic class
include the dual phosphatase (H1L) (Liu et al., 1995),
topoisomerase (H6R) (da Fonseca and Moss, 2003) or the
nucleoside triphosphate phosphohydrolase II (I8R) (Gross and
Shuman, 1996); mutants in all of these proteins can form
particles at non-permissive condition that are indistinguishable
from wt but are deficient in early transcription. These enzymes
therefore probably provide functions essential for transcription
in the unique environment of the core particle, but are not
required for transcription in the soluble system. Proteins in the
structural class include L3L or L4R genes (Resch and Moss,
2005; Wilcock and Smith, 1996); mutants in both these proteins
were able to form virions at non-permissive condition that are
unable to synthesize RNA. Although RNA synthesis in mutant
virions produced by these viruses was reduced in vivo and in the
core transcription system, both mutants contained an active
transcriptional apparatus that recognized an early promoter
based on assays of soluble transcription extracts. However, a
significant difference was observed between L4R and L3L
mutants. Despite the fact that RNA synthesis in both mutants
was reduced from 4 to 20 times respectively, in the L4R mutant
there was also impairment in the release of the transcripts from
the core; this phenomenon did not occur in the L3L mutants. E8
mutants resemble L3L mutants since in these mutants core RNA
synthesis was drastically reduced but the transcripts synthesized
were released from the cores.
Structural considerations may provide additional clues to the
function of the E8 protein. E8 has two hydrophobic domains, it
is a basic protein that can bind to DNA, and it can be
phosphorylated in vitro by the viral F10 protein kinase. Proteins
with these characteristics have been implicated directly or
indirectly in transcription in different cell systems (Berger,
2002; Leo and Chen, 2000; Nowak and Corces, 2004).
Phosphorylation of histone H3 has a role in transcription and
in chromosome condensation (Nowak and Corces, 2000, 2004).
In Drosophila and in cultured mouse cells, the induction of the
heat-shock gene is associated with a significant increase in
histone H3 phosphorylation and an alteration on the transcrip-
tion rate (Dyson et al., 2005b,a). Nuclear receptor phosphoryla-
tion is also associated with a modification of transcription and
an alanine to serine substitution results in a reduction of
transcription activity (Leo and Chen, 2000; Wu et al., 2005).
Thus, E8 has characteristics consistent with a DNA-binding
protein that could modulate virion core transcription.
The vaccinia core contains additional DNA-binding proteins
whose function in virus replication is only partially understood,
notably F17R (VP11) and L4R (VP8) (Kao et al., 1981; Kao
and Bauer, 1987; Nowakowski et al., 1978a,b; Yang et al.,
1988; Yang and Bauer, 1988). F17R is a major DNA-binding
protein and has preferential binding to supercoiled DNA but can
also bind to ssDNA and dsDNA. F17R is phosphorylated on
serine residues and its phosphorylation is minimally dependent
on the viral F10 kinase and modulated by the viral H1
phosphatase and probably by cellular kinases (reviewed in
Condit et al., 2006). Mutants in the F17R gene grown under
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abnormal IV with aberrant internal structures that accumulate in
the cytoplasm of infected cells (Zhang and Moss, 1991). L4
binds to ssDNA, dsDNA and cooperatively to RNA, and as
described above essential for formation of transcriptionally
competent viral particles (Bayliss and Smith, 1997; Wilcock
and Smith, 1994). L4R mutants under non-permissive condi-
tions produce abnormal IV but maturation can also proceed to
produce MV that are indistinguishable in appearance from wt
virions but are 100 fold reduced in infectivity.
Evidence suggests that transcriptional competence of the
vaccinia virion core is tightly coupled to core structure.
Mutants in structural genes A3L, L3L, L4R and now E8R all
form particles that contain an RNA polymerase complex that
is active in a soluble transcription system but inactive in a core
transcription system. Mutants in the major structural protein
A3 (p4b) form morphologically aberrant particles that have
clearly matured beyond the IV stage but lack properly formed
cores. Mutants in the L4 protein, described above, form
normal looking MV however these particles show decreased
stability in the presence of deoxycholate, suggesting a subtle
defect in virion core structure. Mutants in the L3 and now E8
proteins form normal looking particles that, like the A3 and
L4 mutants, are unable to synthesized RNA (Kato et al.,
2004b; Resch and Moss, 2005; Wilcock and Smith, 1996).
Based on these comparisons, we speculate that the function of
E8 protein in virion core, and probably L3 and L4, is to play a
subtle role in virion core structure that impacts directly or
indirectly on core transcription. Ultimately, elucidation of the
precise role of these proteins in vaccinia infection will require
a highly refined description of vaccinia virion core structure
and function.
Materials and methods
Cell and virus culture, plaque assay and one-step growth
BSC40 cells, a continuous line of African green monkey
kidney cells, were used throughout this work. Wild-type
vaccinia virus strains WR and IHDW were used as a control
for the characterization of the temperature mutants: Cts19,
Dts23 and Dts25 (Condit et al., 1983; Condit and Motyczka,
1981; Lackner et al., 2003). The conditions for cell and virus
culture, virus infection, plaque titration and one-step growth
have been described elsewhere (Condit et al., 1983; Condit
and Motyczka, 1981). The non-permissive temperature for
mutant infections was maintained at 39.7 °C; the non-
permissive temperature is labeled as 40 °C in some figures for
convenience.
Viral DNA and plasmid
For sequencing of the E8R gene total infected cell DNAwas
isolated using Qiagen DNeasy miniprep spin columns (Qiagen)
and followed the manufacturer's instructions for isolation of
DNA from cells in culture. Plasmid pSB24, which contains a
synthetic early vaccinia promoter upstream from a 375nucleotide G-less cassette, was obtained from Dr. Stewart
Shuman (Memorial Sloan Kettering Institute). pSB24 was
linearized by digestion with SmaI (NEBiolabs), purified
(Roche-PCR purification kit) and analyzed in a 0.8% agarose–
TAE gel.
DNA sequence analysis
PCR amplification products from total DNA preparations, as
described above, were used to sequence the wild-type and
mutants viruses. Primers that hybridize outside of the coding
sequence were constructed to amplify a 1647-bp product.
Sequence was acquired using amplification primers and primers
that annealed within the coding region. Sequencing was
performed by the University of Florida ICBR DNA Sequencing
Core Laboratory.
Marker rescue
One-step marker rescue was accomplished as described
before with some modifications (Thompson and Condit, 1986).
Briefly, 60-mm dishes of BSC40 cells were infected with each
ts virus at an appropriate moi determined empirically by
terminal dilution for 1 h at 39.7 °C. After this time, the inoculum
was removed and 4 ml of OPTI-MEM was added to the culture.
The cells were transfected with 1.5 μg of a PCR product using
Lipofectamine reagent (Invitrogen) and incubated for 4 days at
non-permissive temperature. After this time, the dishes were
stained with crystal violet. For the initial mapping experiments,
PCR amplifications were performed using a library of primers
designed to create 13 overlapping 20 kbp products that
collectively span the vaccinia genome (Yao and Evans, 2003),
as shown on the top of Fig. 1. Once a region on the vaccinia
genome was identified a second set of PCR products of 5 kbp
each were used based on the library described by Luttge and
Moyer (2005). Once the mutated region was identified
individual open reading frames in that 5 kbp region were
amplified from genomic viral DNA and used in a subsequent
marker rescue experiment to map each mutant to an individual
gene.
Analyses of VV DNA slot-blot hybridization
Confluent 35-mm dishes of BSC40 were infected with
VACVas described. At different times post-infection cells were
harvested and extracts were prepared as described previously
(Damaso et al., 2002). Samples of each extract were applied in
triplicate to a Hybond-N membrane (GE-Healthcare) using a
Slot Blot Minifold II apparatus (Schleicher and Schuell, Inc.).
After filtration, the DNAwas denatured in situ and probed with
a 32P end-labeled oligonucleotide mixture that represents
several genes from the VAC genome. Hybridization carried
out for 18 h at 42 °C in hybridization solution 67 (6× SSC; 0.1%
SDS; 10× Denhardts, 100 μ/ml ssDNA). The blots were washed
threw times in 5× SSC, 1% SDS, once at 30 °C, and twice at
50 °C and analyzed with a phosphor-imager apparatus (Storm
860, GE-Healthcare).
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Metabolic labeling of proteins was performed by incubating
infected cells with 35S-labeled amino acids mixture (ProMix-
GE Healthcare) in a methionine free media for 30 min. The cells
were resuspended in SDS-sample buffer (50 mM Tris–HCl, pH
6.8; 1% SDS; 10% glycerol; 140 mM 2-mercaptoethanol; 0.1%
bromophenol blue) and sodium dodecyl sulfate–polyacryla-
mide gel electrophoresis (SDS–PAGE), and autoradiography
was done as described previously (Condit and Motyczka, 1981;
Kato et al., 2004b).
Purification and analysis of virus particles
Six 150-mm dishes containing confluent monolayers of
BSC40 cells were infected with either VACV-IHD-W or Dts23
viruses at an moi of 10 at the permissive or the non-permissive
temperature. Cells incubated at 39.7 °Cwere harvested 24 h after
infection and the cells incubated at 31 °C were harvested after
72 h of infection. Cell-associated virus was purified by dif-
ferential centrifugation through a 36% sucrose cushion followed
by banding on a 24–40% sucrose gradient as previously
described (Ausubel et al., 1994; Kato et al., 2004b). Similar
procedure was done with VAC-WR and Cts19 but the viruses
were incubated only at 31 °C.
Western blot analysis
Virion core and envelope extracts were prepared and
analyzed by incubating 0.06 A260 nm units (0.7 μg) of wt or
mutant particles with core buffer (100 mMDTTand 1%NP40 in
50 mM Tris–HCl pH 8.0) for 30 min at 37 °C. Core and
membrane fractions were partitioned by a 15 min centrifugation
at 20,000×g. The fractions were resuspended in SDS-sample
buffer and the proteins were separated by a 12% SDS–PAGE
and transferred to a nitrocellulose membrane as described (Black
et al., 1998). The membranes were blocked with a solution of
TBS-T (50 mM Tris–HCl pH 7.5; 150 mMNaCl; 0.01% Tween
20) and 5% non-fat dry milk (TBS-TM) for 1 h, washed twice
with TBS-T and incubated with an appropriate dilution of the
primary antibody in TBS-TM for 2 h. Peptide base rabbit
polyclonal antibodies specific for the E8 protein (amino acids
177 to 190) were prepared by Sigma Genosys Inc and used at a
dilution of 1:1000. The dilution and source of the other
antibodies were the following: anti-F11 (1:1000) (Kato et al.,
2004a); anti-L4 (1:40.000) rabbit serum was supplied by Dr.
Dennis Hruby (Oregon State University); anti-H4 (1:5000)
rabbit serumwas supplied byDr. BernardMoss (NIAID); anti A-
27 (1:40.000) monoclonal antibody supplied by Dr. David
Ulaeto, Department of Biological Science, DSTL, Porton Down,
Salisbury, UK.
Electron microscopy
BSC40 cells on 60-mm dishes were infected with either wt or
mutant viruses at an moi of 10 at either 31 or 39.7 °C. Samples
from 24 to 48 post-infection were prepared for transmissionelectron microscopy with assistance of the University of Florida
ICBR Electron Microscopy Core Laboratory (Kato et al.,
2004b).
Confocal microscopy
BSC40 cells grown on an 8-well glass slide (BD-Falcon)
were infected with 1000 particles per cell for 1 h at 4 °C. After
this incubation the unabsorbed virus was removed, the cells were
washed once with PBS and incubated at 31 °C in DMEM
containing 100 μg/ml of cycloheximide for 2 h. Next the cells
were fixed with 4% paraformaldehyde, permeabilized with 0.1%
saponin and incubated for 1 h with anti-A4 antibody (Dr
Mariano Esteban, Centro Nacional de Biotecnologia, CSIC,
Madrid, Spain). Cy2 labeled goat-anti-rabbit antibody (Jackson
Immunoresearch Laboratories, Inc.) was used as secondary
antibody for visualization of A4 and DNA staining was stained
with DAPI (Vectashield, Vector Laboratories, Inc., CA). The
slides were observed on a Leica Confocal microscope (Leica
TCS SP5).
RNA isolation and Northern blotting
BSC40 cells were infected with wt and mutant virus at an moi
of 1000 particles per cell. At indicated time points the cells were
washed with PBS and total RNAwas isolated using an RNeasy
kit (Qiagen) following the protocol described by the manufac-
turer. For the Northern blot procedure, RNAs were mixed with
RNA sample loading buffer (Sigma-Aldrich), denatured by
incubating at 70 °C for 10 min and loaded onto a 1.2% agarose
gel containing 2.2 M formaldehyde and 1× MOPS buffer
(20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA, pH 7.0).
Samples were electrophoresed at 80 V for 90 min. The gel was
soaked in water, treated with 0.05 N NaOH and twice washed in
20× SSC (1× SSC=15 mM sodium citrate, 150 mM sodium
chloride) for 20 min at each step. The RNAs were transferred
overnight to a GeneScreen neutral charge membrane (PerkinEl-
mer, Boston, MA) and processed as described (Cresawn et al.,
2007).
Transcription by permeabilized virions
Permeabilized virion transcription reactions were done
essentially as described previously (Kato et al., 2004b). 0.4
A260 nm units of virus was incubated in a reaction mixture
containing 60 mM Tris–HCl pH 8.0, 0.05% Nonidet P40
(NP40), 10 mM dithiothreitol (DTT), 10 mM MgCl2, 5 mM
ATP, 1 mM UTP, 1 mM GTP, 0.2 mM α-32P-CTP (100 μCi/
μmol), at 31 °C. At various times 50-μl aliquots were removed,
precipitated directly with 5% TCA, filtered onto a glass
microfiber filters (934-AH, Whatman) and the radioactivity
was determined by liquid scintillation counting.
Preparation and assay of soluble virion transcription extracts
Soluble transcription extracts were prepared and assayed as
described by Moussatché (1985) with modifications. All
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5.0 A260 nm units of virus was resuspended in 800 μl of core
buffer (50mMTris–HCl pH 8.0, 10mMDTT, 0.05%NP40) and
incubated for 10 min at room temperature. The cores were
collected by a 2 min centrifugation in an Eppendorf microfuge
and resuspended in 150 μl of Buffer N (300 mM Tris–HCl, pH
8.0, 250 mM KCl, 50 mM DTT). Deoxycholate was added to a
final concentration of 0.15% and the mixture incubated for
30 min on ice with occasionally gentle mixing. Glycerol was
added to a 10% final concentration and the extract was cen-
trifuged for 5 min at 20,000×g. The supernatant was collected
and applied to a 150 μl DEAE column equilibrated in Buffer M
(50 mM Tris–HCl, pH 8.0, 250 mM KCl, 1 mM EDTA pH 8.0,
0.1% Triton X-100, 3 mM DTT). One hundred microliter
fractions were collected and assayed for non-specific RNA
polymerase activity in 100 μl reactions containing: 60 mMTris–
HCl, pH 8.0, 10mMDTT, 3mMMnCl2, 1mMATP, 1mMGTP,
1 mM UTP, 0.1 mM α 32P-CTP (25 μCi/μmol), 1 μg ssDNA
(from bacteriophage M13) and 8 μl of enzyme. The reactions
were incubated for 30 min at 31 °C and the radiolabeled RNA
was measured by precipitation with 5% TCA. Peak fractions
were pooled and stored in aliquots at −80 °C. Promoter-specific
transcription by virion extracts was assayed as follows: 100 μl
reactions containing 40 mM Hepes–KOH, pH 8.0, 5 mM DTT,
6 mM MgCl2, 2 mM spermidine, 2 mM ATP, 2 mM UTP,
0.01 mM α 32P-CTP (3000 Ci/mM), 0.24 μg pSB24 DNA
linearized with SmaI and 2 to 6 μl of enzyme was incubated at
31 °C for 15 min. Reactions contained equivalent amounts of
RNA polymerase activity, determined by performing a time
course of non-specific transcription with varying amounts of
virion extract. RNAwas purified from transcription reactions by
proteinase K treatment and phenol/chloroform extraction and
ethanol precipitation, resuspended in RNA SB (95% formamide,
20 mM EDTA, 0.1 μg Bromophenol blue, 0.1 μg of xylene
cyanole) and analyzed by electrophoresis on 6% denaturing
polyacrylamide/urea gels.
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